Schwann Direction: dECM-based Implants for Peripheral Nerve Regeneration
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB |
| Funding from Vinnova | SEK 985 938 |
| Project duration | October 2024 - October 2025 |
| Status | Ongoing |
| Venture | Preparation projects for international application within health |
| Call | Towards deeper collaboration with UK and USA partners within Health and Life Science |
Purpose and goal
The goal for this project is to build a well-rounded international consortium focused on a long-term project plan for developing advanced therapies for peripheral nerve regeneration. This consortium will focus on industrial and academic partners from Sweden and UK. From the proof-of-concept results, this will help us decide on the long-term strategy and kind of nerve implant needed to go forward.
Expected effects and result
Expected outcomes and effects of the project involve the establishment of a novel interdisciplinary collaboration that advances therapies for peripheral nerve injuries. Our starting point for this long-term consortium is a proof-of-concept (PoC) nerve implant from combined expertise. The anticipated outcomes include an efficient, scalable implant prototype, a strengthened consortium for long-term research, and a framework for navigating market, intellectual property, and regulatory pathways.
Planned approach and implementation
The project is structured around key work packages aimed at a long-term strategy to address Peripheral Nerve Injuries in patients. The project consists of four main work packages: WP 1 focuses on creating and testing a proof of concept (PoC) for the nerve regeneration scaffold. WP 2 aims to build consortium competencies, the roadmap for regulatory approval, and potential partnerships. WP 3 involves comprehensive market and intellectual property analysis. WP 4 is on project management.